Back to Search Start Over

805 Mitogen-activated protein kinase (MAPK) and Akt as predictive factors for response to ZD 1839 therapy in non-small cell lung cancer (NSCLC) patients.

Authors :
Capuzzo, F.
Gregorc, V.
Bencardino, K.
Lombardo, L.
Magrini, E.
Paties, T.C.
Ceresoli, G.L.
Bartolini, S.
Villa, E.
Crino, L.
Source :
EJC Supplements; Sep2003, Vol. 1 Issue 5, pS242-S242, 1p
Publication Year :
2003

Details

Language :
English
ISSN :
13596349
Volume :
1
Issue :
5
Database :
Supplemental Index
Journal :
EJC Supplements
Publication Type :
Academic Journal
Accession number :
17014925
Full Text :
https://doi.org/10.1016/s1359-6349(03)90830-5